Citations (68)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Stephanie C Yoon & Heather C Bruner. (2017) Naloxegol in opioid-induced constipation: a new paradigm in the treatment of a common problem. Patient Preference and Adherence 11, pages 1265-1271.
Read now
Read now
Gineke Koopmans-Klein, Joeri Van Op den Bosch, Yvonne van Megen, Hans Prenen, Frank Huygen & Isabelle Mancini. (2017) Prolonged release oxycodone and naloxone treatment counteracts opioid-induced constipation in patients with severe pain compared to previous analgesic treatment. Current Medical Research and Opinion 33:12, pages 2217-2227.
Read now
Read now
Gineke Koopmans-Klein, Michel F.M. Wagemans, Hans C.H. Wartenberg, Yvonne J.B. Van Megen & Frank J.P.M. Huygen. (2016) The efficacy of standard laxative use for the prevention and treatment of opioid induced constipation during oxycodone use: a small Dutch observational pilot study. Expert Review of Gastroenterology & Hepatology 10:4, pages 547-553.
Read now
Read now
Amir Rumman, Zane R. Gallinger & Louis W. C. Liu. (2016) Opioid induced constipation in cancer patients: pathophysiology, diagnosis and treatment. Expert Review of Quality of Life in Cancer Care 1:1, pages 25-35.
Read now
Read now
Heather C Bruner, Rabia S Atayee, Kyle P Edmonds & Gary T Buckholz. (2015) Clinical utility of naloxegol in the treatment of opioid-induced constipation. Journal of Pain Research 8, pages 289-294.
Read now
Read now
Wojciech Leppert. (2015) Emerging therapies for patients with symptoms of opioid-induced bowel dysfunction. Drug Design, Development and Therapy 9, pages 2215-2231.
Read now
Read now
Gineke Koopmans, Karen Simpson, Javier De Andrés, Eberhard Albert Lux, Michel Wagemans & Yvonne Van Megen. (2014) Fixed ratio (2:1) prolonged-release oxycodone/naloxone combination improves bowel function in patients with moderate-to-severe pain and opioid-induced constipation refractory to at least two classes of laxatives. Current Medical Research and Opinion 30:11, pages 2389-2396.
Read now
Read now
Articles from other publishers (61)
Ryota Sato, Mayumi Ishida, Nozomu Uchida, Takehiko Sakimoto, Takefumi Yamaguchi, Yoshitaka Ooya, Takao Takahashi & Hideki Onishi. (2023) Naldemedine-induced opioid withdrawal with restlessness as the predominant symptom in a palliative care setting. Palliative and Supportive Care, pages 1-3.
Crossref
Crossref
David Harris, David Kalir, Cory Chevalier, Krista Dobbie, Flannery Fielding, Ruth Lagman, Ahed Makhoul, Susan McInnes, Sina Najafi, Kyle Neale, Lisa Rybicki, Melanie Robbins-Ong & Kathleen Neuendorf. (2022) Response Rates to Methylnaltrexone in Hospitalized Cancer Patients. American Journal of Hospice and Palliative Medicine®, pages 104990912211479.
Crossref
Crossref
Zeynep Pehlivan & Nesrin Nural. (2022) Prevalence of constipation in patients undergoing chemotherapy and the effect of constipation on quality of life. Supportive Care in Cancer 30:10, pages 8019-8028.
Crossref
Crossref
Shintaro Kato, Yoshitaka Saito, Hiroko Onoda, Masayoshi Kumai, Shungo Imai, Kenkichi Tsuruga, Yoh Takekuma & Mitsuru Sugawara. (2022) Efficacy Survey of Naldemedine in the Poor-performance Status GroupPerformance Status不良群におけるナルデメジンの有効性の検証. YAKUGAKU ZASSHI 142:7, pages 755-760.
Crossref
Crossref
Jee-Hyun Yoon, Su Bin Park, Eun Hye Kim, Jee Young Lee & Seong Woo Yoon. (2022) A Case Report on Opioid-Induced Constipation in a Patient with Cancer Treated by <italic>Jowiseunggi-tang</italic>. The Journal of Internal Korean Medicine 43:2, pages 229-236.
Crossref
Crossref
Jeffrey Gudin, Ly Vu, Mariana Rubini Ceschim, Luis Gude, Evan Peskin, Armando Alvarez & Danielle Bodzin Horn. (2022)
Peripherally acting
mu‐opioid
receptor antagonists for the treatment of opioid‐induced constipation
. Alimentary Pharmacology & Therapeutics 55:S2.
Crossref
Crossref
Thanh Hang Chu, Manuela Rueter, Aurore Palmaro & Maryse Lapeyre‐Mestre. (2021) Potential inappropriate use of strong opioid analgesics in cancer outpatients during the last year of life in France and associated factors. British Journal of Clinical Pharmacology 88:4, pages 1691-1703.
Crossref
Crossref
Hiroaki Abe, Masahiko Sumitani, Hiroki Matsui, Reo Inoue, Kiyohide Fushimi, Kanji Uchida & Hideo Yasunaga. (2022) Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid‐induced constipation: A nationwide retrospective cohort study in Japan. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 42:3, pages 241-249.
Crossref
Crossref
Jesse J. Di Cello, Arisbel B. Gondin, Simona E. Carbone & Daniel P. Poole. 2022. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics. Treatments, Mechanisms, and Adverse Reactions of Anesthetics and Analgesics
227
234
.
Regina Gironés Sarrió, Agnès Calsina-Berna, Adoración Gozalvo García, José Miguel Esparza-Miñana, Esther Falcó Ferrer & Josep Porta-Sales. (2021) Delphi consensus on strategies in the management of opioid-induced constipation in cancer patients. BMC Palliative Care 20:1.
Crossref
Crossref
Giustino Varrassi, Vivek Banerji, Walter Gianni, Franco Marinangeli & Carmine Pinto. (2021) Impact and Consequences of Opioid-Induced Constipation: A Survey of Patients. Pain and Therapy 10:2, pages 1139-1153.
Crossref
Crossref
Antoine Lemaire, Yoann Pointreau, Bérengère Narciso, François-Xavier Piloquet, Viorica Braniste & Jean-Marc Sabaté. (2021) Effectiveness of naloxegol in patients with cancer pain suffering from opioid-induced constipation. Supportive Care in Cancer 29:12, pages 7577-7586.
Crossref
Crossref
Junya Hashizume, Kyohei Shiojiri, Emi Ryu, Yuki Kawauchi, Kyoko Hasegawa, Nozomi Ezaki, Haruna Yamashita, Koji Ishii, Hitomi Harasawa, Tadahiro Nakamura, Hitoshi Sasaki & Yukinobu Kodama. (2021) Analysis of Predictive Factors for Diarrhea after the Administration of Naldemedine. Biological and Pharmaceutical Bulletin 44:8, pages 1081-1087.
Crossref
Crossref
Martina Rekatsina, Antonella Paladini, Asbjørn M Drewes, Farrah Ayob, Omar Viswanath, Ivan Urits, Oscar Corli, Joseph Pergolizzi Jr & Giustino Varrassi. (2021) Efficacy and Safety of Peripherally Acting μ-Opioid Receptor Antagonist (PAMORAs) for the Management of Patients With Opioid-Induced Constipation: A Systematic Review. Cureus.
Crossref
Crossref
Karen Ryan, Bridget M. Johnston, Clare McAleer, Laserina O'Connor & Philip Larkin. (2022) A national cross-sectional survey of constipation in patients attending cancer centres in Ireland. HRB Open Research 4, pages 113.
Crossref
Crossref
Karen Ryan, Bridget M. Johnston, Clare McAleer, Laserina O'Connor & Philip Larkin. (2021) A national cross-sectional survey of constipation in patients attending cancer centres in Ireland. HRB Open Research 4, pages 113.
Crossref
Crossref
Demis N. Lipe. 2021. Oncologic Emergency Medicine. Oncologic Emergency Medicine
367
375
.
Nesrine Kallel, Zahra Charmi, Rim Khemekhem, Sameh Msaad, Ilhem Yangui & Samy Kammoun. (2020) Constipation induite par les opioïdes chez les patients suivis pour cancer du poumon. Médecine Palliative 19:6, pages 356-360.
Crossref
Crossref
Miku Iida, Kohime Oshita, Ryousuke Wakamatsu, Yusuke Nakano, Sumire Iwamoto, Hiroo Suto, Chinami Suzuki, Hideharu Obara, Akio Shibanami & Kazuya Hiura. (2020) Efficacy of Naldemedine and Sennoside for Opioid-induced Constipation: Retrospective Comparison Study Using the Inverse Probability of Treatment Weightingオピオイド誘発性便秘症に対するナルデメジンとセンノシドの有効性；IPTW法を用いた後方視的比較検討. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences) 46:11, pages 672-678.
Crossref
Crossref
Timothy J. Brown, Neil Keshvani, Arjun Gupta, Hui Yang, Deepak Agrawal, Tri C. Le, David E. Gerber & Carlos A. Alvarez. (2020) Rates of appropriate laxative prophylaxis for opioid-induced constipation in veterans with lung cancer: a retrospective cohort study. Supportive Care in Cancer 28:11, pages 5315-5321.
Crossref
Crossref
Kei Kawada, Tsuyoshi Ohta, Hitoshi Fukuda, Toshinobu Hayashi, Koudai Tanaka, Toshi Imai, Yasuyo Morita & Mitsuhiko Miyamura. (2020) Effect of lubiprostone on vinca alkaloid–induced constipation in patients with hematological malignancies: a propensity score–matched analysis. Annals of Hematology 99:10, pages 2429-2436.
Crossref
Crossref
Nazli ÖZTÜRK, Burcu ÇELİK KOCABIYIK, Fatma ARIKAN & Hasan Şenol COŞKUN. (2020) Kanser Hastalarında Konstipasyon Sıklığı ve Gelişme Riskinin İncelenmesiInvestigation of Constipation Frequency and Development Risk in Cancer Patients. Dokuz Eylül Üniversitesi Hemşirelik Fakültesi Elektronik Dergisi 13:3, pages 178-184.
Crossref
Crossref
İsmail Toygar, Öznur Usta Yeşilbalkan, Merve Kürkütlü & Abdullah Aslan. (2020) Complementary and alternative medicines used by cancer patients to cope with chemotherapy-induced constipation. Complementary Therapies in Clinical Practice 39, pages 101108.
Crossref
Crossref
Eric J. Roeland, Christopher J. Sera & Joseph D. Ma. (2019) More opioids, more constipation? Evaluation of longitudinal total oral opioid consumption and self-reported constipation in patients with cancer. Supportive Care in Cancer 28:4, pages 1793-1797.
Crossref
Crossref
Philippa Hawley, Hannah MacKenzie & Monica Gobbo. (2019) PEG vs. sennosides for opioid-induced constipation in cancer care. Supportive Care in Cancer 28:4, pages 1775-1782.
Crossref
Crossref
Junya Hashizume, Emi Ryu, Seiichi Nose, Kei Miyanaga, Reiko Kishikawa, Tadahiro Nakamura, Takahiro Muro, Yukinobu Kodama, Haruna Yamashita, Koji Ishii & Hitoshi Sasaki. (2020) Predictors for Diarrhea After Administration of Naldemedine: Analysis Focusing on the Administration Period of Opioid Analgesics Before the Start of Naldemedineナルデメジン導入後の下痢発現に関する予測因子─ナルデメジン導入前のオピオイド鎮痛薬の投与期間に着目した解析─. Palliative Care Research 15:2, pages 101-109.
Crossref
Crossref
Guillem Vicente, Salvador Bofill Francisco Javier, Feyjoo Margarita, Antón Antonio, Aranda Enrique, Camps Carlos, Carrato Alfredo, Constenla Manuel, Cruz-Hernández Juan Jesús, Díaz-Rubio Eduardo, García-Foncillas Jesús, Gascón Pere, López Rafael, Soler Begoña & Escobar Yolanda. (2019) Clinical practice evaluation of opioids induced constipation management in patients with cancer: The EIO-50 project. Open Journal of Pain Medicine, pages 034-040.
Crossref
Crossref
Soler Begona. (2019) Analysis of care for cancer patients with opioid-induced constipation in clinical practice: EIO-PRAXIS Project. Open Journal of Pain Medicine 3:1, pages 027-033.
Crossref
Crossref
Ricard Mesía, Juan Antonio Virizuela Echaburu, Jose Gómez, Tamara Sauri, Gloria Serrano & Eduardo Pujol. (2019) Opioid-Induced Constipation in Oncological Patients: New Strategies of Management. Current Treatment Options in Oncology 20:12.
Crossref
Crossref
James Wild, Tadaaki Yamada, Juan Camilo Arjona Ferreira & Martin Hale. (2019) Onset of action of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: results from 2 randomized, placebo-controlled, phase 3 trials. Pain 160:10, pages 2358-2364.
Crossref
Crossref
Namisha Thapa, Matthew Kappus, Ryan Hurt & Sarah Diamond. (2019) Implications of the Opioid Epidemic for the Clinical Gastroenterology Practice. Current Gastroenterology Reports 21:9.
Crossref
Crossref
Pei-Ming Wang, Ching-Wen Hsu, Chun-Ting Liu, Ting-Yu Lai, Fe-Ling Tzeng & Chih-Fang Huang. (2019) Effect of acupressure on constipation in patients with advanced cancer. Supportive Care in Cancer 27:9, pages 3473-3478.
Crossref
Crossref
Akihiro Tokoro, Hisao Imai, Soichi Fumita, Toshiyuki Harada, Toshio Noriyuki, Makio Gamoh, Yusaku Akashi, Hiroki Sato & Yoshiyuki Kizawa. (2019) Incidence of opioid‐induced constipation in Japanese patients with cancer pain: A prospective observational cohort study. Cancer Medicine 8:10, pages 4883-4891.
Crossref
Crossref
Xinjun Wang, Boli Yang, Jieyun Yin, Wei Wei & Jiande D. Z. Chen. (2019) Electroacupuncture via chronically implanted electrodes improves gastrointestinal motility by balancing sympathovagal activities in a rat model of constipation. American Journal of Physiology-Gastrointestinal and Liver Physiology 316:6, pages G797-G805.
Crossref
Crossref
Kenichi Nishie, Shuhei Yamamoto, Takayoshi Yamaga, Naoto Horigome & Masayuki Hanaoka. (2019) Peripherally acting μ‐opioid antagonist for the treatment of opioid‐induced constipation: Systematic review and meta‐analysis. Journal of Gastroenterology and Hepatology 34:5, pages 818-829.
Crossref
Crossref
Perry G. Fine, Yen-Wen Chen, Eric Wittbrodt & Catherine Datto. (2018) Impact of opioid-induced constipation on healthcare resource utilization and costs for cancer pain patients receiving continuous opioid therapy. Supportive Care in Cancer 27:2, pages 687-696.
Crossref
Crossref
Brian Hanson, Shazia Mehmood Siddique, Yolanda Scarlett & Shahnaz Sultan. (2019) American Gastroenterological Association Institute Technical Review on the Medical Management of Opioid-Induced Constipation. Gastroenterology 156:1, pages 229-253.e5.
Crossref
Crossref
John M. Streicher & Edward J. Bilsky. (2017) Peripherally Acting μ-Opioid Receptor Antagonists for the Treatment of Opioid-Related Side Effects: Mechanism of Action and Clinical Implications. Journal of Pharmacy Practice 31:6, pages 658-669.
Crossref
Crossref
Xiuju Cheng, Shougang Wei, Huapeng Zhang, Senyao Xue, Wei Wang & Kaikai Zhang. (2018) Nurse-led interventions on quality of life for patients with cancer. Medicine 97:34, pages e12037.
Crossref
Crossref
Hua-dong ZhuZhen GongBing-wei HuQiao-ling WeiJun KongCong-bin Peng. (2017) The Efficacy and Safety of Transcutaneous Acupoint Interferential Current Stimulation for Cancer Pain Patients With Opioid-Induced Constipation: A Prospective Randomized Controlled Study. Integrative Cancer Therapies 17:2, pages 437-443.
Crossref
Crossref
Bart J. Morlion, Stefan A. Mueller‐Lissner, Renato Vellucci, Wojciech Leppert, Benoît C. Coffin, Sara L. Dickerson & Tony O'Brien. (2017) Oral Prolonged‐Release Oxycodone/Naloxone for Managing Pain and Opioid‐Induced Constipation: A Review of the Evidence. Pain Practice 18:5, pages 647-665.
Crossref
Crossref
N. Katakami, T. Harada, T. Murata, K. Shinozaki, M. Tsutsumi, T. Yokota, M. Arai, Y. Tada, M. Narabayashi & N. Boku. (2018) Randomized phase III and extension studies: efficacy and impacts on quality of life of naldemedine in subjects with opioid-induced constipation and cancer. Annals of Oncology 29:6, pages 1461-1467.
Crossref
Crossref
Jason W. BolandVictoria AllgarElaine G. BolandOsaretin OviasuMeera AgarDavid C. CurrowMiriam J. Johnson. (2017) Effect of Opioids and Benzodiazepines on Clinical Outcomes in Patients Receiving Palliative Care: An Exploratory Analysis. Journal of Palliative Medicine 20:11, pages 1274-1279.
Crossref
Crossref
D. Dupoiron, A. Stachowiak, O. Loewenstein, A. Ellery, W. Kremers, B. Bosse & M. Hopp. (2017) A phase III randomized controlled study on the efficacy and improved bowel function of prolonged-release (PR) oxycodone-naloxone (up to 160/80 mg daily) vs oxycodone PR. European Journal of Pain 21:9, pages 1528-1537.
Crossref
Crossref
Joseph V. Pergolizzi Jr. Robert B. Raffa, Emilio Esteban Gonzalez & Jo Ann LeQuang. (2017) A Guide for Cancer Pain Management in Latin America. Journal of Cancer Research Updates 6:4, pages 81-96.
Crossref
Crossref
Robert S. Epstein, J. Russell Teagarden, Ali Cimen, Mark Sostek & Tehseen Salimi. (2017) When People with Opioid-Induced Constipation Speak: A Patient Survey. Advances in Therapy 34:3, pages 725-731.
Crossref
Crossref
Stefan Müller-Lissner, Gabrio Bassotti, Benoit Coffin, Asbjørn Mohr Drewes, Harald Breivik, Elon Eisenberg, Anton Emmanuel, Françoise Laroche, Winfried Meissner & Bart Morlion. (2016) Opioid-Induced Constipation and Bowel Dysfunction: A Clinical Guideline. Pain Medicine, pages pnw255.
Crossref
Crossref
Rachel M. McQuade, Vanesa Stojanovska, Raquel Abalo, Joel C. Bornstein & Kulmira Nurgali. (2016) Chemotherapy-Induced Constipation and Diarrhea: Pathophysiology, Current and Emerging Treatments. Frontiers in Pharmacology 7.
Crossref
Crossref
Nancy Y. ChenEugene Nguyen, Sheree M. Schrager & Christopher J. Russell. (2016) Factors Associated With the Prophylactic Prescription of a Bowel Regimen to Prevent Opioid-Induced Constipation. Hospital Pediatrics 6:11, pages 677-683.
Crossref
Crossref
Mei Krishnasamy & Raymond J. Chan. (2016) Translational Cancer Nursing Research. Cancer Nursing 39:6, pages 425-426.
Crossref
Crossref
Claire Gervais, Philippe Ducrotté, Thierry Piche, Mario Di Palma, Nicolas Jovenin & Florian Scotté. (2016) Constipation et cancer : stratégies actuelles. Bulletin du Cancer 103:9, pages 794-804.
Crossref
Crossref
Sita Chokhavatia, Elizabeth S. John, Mary Barna Bridgeman & Deepali Dixit. (2016) Constipation in Elderly Patients with Noncancer Pain: Focus on Opioid-Induced Constipation. Drugs & Aging 33:8, pages 557-574.
Crossref
Crossref
Karin S. Coyne, Chris Sexton, Robert J. LoCasale, Frederic R. King, Mary Kay Margolis & Sam H. Ahmedzai. (2016) Opioid-Induced Constipation among a Convenience Sample of Patients with Cancer Pain. Frontiers in Oncology 6.
Crossref
Crossref
Irene Sonu, George Triadafilopoulos & Jerry D Gardner. (2016) Persistent constipation and abdominal adverse events with newer treatments for constipation. BMJ Open Gastroenterology 3:1, pages e000094.
Crossref
Crossref
Helene Nordahl Christensen, Urban Olsson, Jesper From & Harald Breivik. (2016) Opioid-induced constipation, use of laxatives, and health-related quality of life. Scandinavian Journal of Pain 11:1, pages 104-110.
Crossref
Crossref
M. Nilsson, T. H. Sandberg, J. L. Poulsen, M. Gram, J. B. Frøkjaer, L. R. Østergaard, K. Krogh, C. Brock & A. M. Drewes. (2015) Quantification and variability in colonic volume with a novel magnetic resonance imaging method. Neurogastroenterology & Motility 27:12, pages 1755-1763.
Crossref
Crossref
R. J. LoCasale, C. J. Datto, M. K. Margolis, J. Tack & K. S. Coyne. (2015) The impact of opioid-induced constipation among chronic pain patients with sufficient laxative use. International Journal of Clinical Practice 69:12, pages 1448-1456.
Crossref
Crossref
Lynn R. Webster. (2015) Opioid-Induced Constipation. Pain Medicine 16:suppl 1, pages S16-S21.
Crossref
Crossref
Bart Morlion, Katri Elina Clemens & Will Dunlop. (2014) Quality of Life and Healthcare Resource in Patients Receiving Opioids for Chronic Pain: A Review of the Place of Oxycodone/Naloxone. Clinical Drug Investigation 35:1, pages 1-11.
Crossref
Crossref
. 2014. Kratom and Other Mitragynines. Kratom and Other Mitragynines
274
297
.
Xiao Li, Guoqi Li, Shaoling Wu, Baiyu Zhang, Qing Wan, Ding Yu, Ruijun Zhou & Chao Ma. (2014) Antinociceptive Effect of Intrathecal Microencapsulated Human Pheochromocytoma Cell in a Rat Model of Bone Cancer Pain. International Journal of Molecular Sciences 15:7, pages 12135-12148.
Crossref
Crossref